TrialThe lancet. HIV2019

Adeno-associated virus vectored immunoprophylaxis to prevent HIV in healthy adults: a phase 1 randomised controlled trial.

Frances H Priddy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.